NASDAQ : HALO
Halozyme Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 130.91 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.86B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Halozyme Therapeutics, Inc. (HALO) reported revenue of 1.66B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.66B | 1.40B | 1.02B | 829.25M | 660.12M | 443.31M |
| Cost of Revenue | 394.79M | 310.26M | 238.47M | 268.72M | 205.91M | 117.08M |
| Gross Profit | 1.27B | 1.09B | 776.86M | 560.53M | 454.20M | 326.23M |
| Selling, General & Admin | 224.29M | 193.39M | 154.34M | 149.18M | 121.63M | 50.32M |
| Amortization of Goodwill & Intangibles | 100.16M | 76.66M | 71.05M | 73.77M | 43.15M | |
| Operating Expenses | 324.46M | 270.05M | 225.38M | 222.96M | 164.77M | 50.32M |
| Operating Income | 944.49M | 816.29M | 551.48M | 337.57M | 289.43M | 275.90M |
| Interest Expense | -20.30M | -18.13M | -18.09M | -18.76M | -16.95M | -7.53M |
| Interest & Investment Income | 10.66M | 18.00M | 12.83M | 10.00M | 3.88M | 3.36M |
| EBT Excluding Unusual Items | 934.85M | 816.17M | 546.21M | 328.81M | 276.36M | 271.74M |
| Merger & Restructuring Charges | -13.70M | -13.70M | -21.90M | |||
| Gain (Loss) on Sale of Investments | 1.25M | 3.47M | 10.93M | 6.32M | -2.83M | -2.26M |
| Asset Writedown | -48.70M | -48.70M | ||||
| Other Unusual Items | -5.48M | -5.48M | 13.20M | -2.71M | -20.96M | |
| Pretax Income | 583.34M | 466.88M | 557.13M | 348.33M | 248.92M | 248.52M |
| Income Tax Expense | 169.74M | 149.99M | 113.04M | 66.73M | 46.79M | -154.19M |
| Net Income | 413.60M | 316.89M | 444.09M | 281.59M | 202.13M | 402.71M |
| Net Income to Common | 413.60M | 316.89M | 444.09M | 281.59M | 202.13M | 402.71M |
| Shares Outstanding (Basic) | 117.56M | 119.84M | 126.83M | 131.93M | 136.84M | 140.65M |
| Shares Outstanding (Diluted) | 122.22M | 123.90M | 129.42M | 134.20M | 140.61M | 146.80M |
| EPS (Basic) | 3.52 | 2.64 | 3.50 | 2.13 | 1.48 | 2.86 |
| EPS (Diluted) | 3.38 | 2.56 | 3.43 | 2.10 | 1.44 | 2.74 |
| Free Cash Flow | 806.22M | 644.59M | 468.37M | 373.28M | 235.30M | 297.98M |
| Free Cash Flow Per Share | 6.60 | 5.20 | 3.62 | 2.78 | 1.67 | 2.03 |
| Gross Margin | 76.27% | 77.78% | 76.51% | 67.59% | 68.81% | 73.59% |
| Operating Margin | 56.77% | 58.45% | 54.32% | 40.71% | 43.84% | 62.24% |
| Profit Margin | 24.86% | 22.69% | 43.74% | 33.96% | 30.62% | 90.84% |
| Free Cash Flow Margin | 48.46% | 46.15% | 46.13% | 45.01% | 35.64% | 67.22% |
| EBITDA | 1.05B | 897.84M | 627.09M | 416.93M | 336.07M | 277.30M |
| EBITDA Margin | 63.15% | 64.29% | 61.76% | 50.28% | 50.91% | 62.55% |
| D&A For EBITDA | 106.20M | 81.55M | 75.61M | 79.36M | 46.64M | 1.40M |
| EBIT | 944.49M | 816.29M | 551.48M | 337.57M | 289.43M | 275.90M |
| EBIT Margin | 56.77% | 58.45% | 54.32% | 40.71% | 43.84% | 62.24% |
| Effective Tax Rate | 29.10% | 32.13% | 20.29% | 19.16% | 18.80% | |
| Revenue as Reported | 1.66B | 1.40B | 1.02B | 829.25M | 660.12M | 443.31M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 163.14M | 133.82M | 115.85M | 118.37M | 234.19M | 118.72M |
| Short-Term Investments | 67.86M | 9.00M | 480.22M | 217.63M | 128.60M | 622.20M |
| Cash & Short-Term Investments | 231.00M | 142.82M | 596.07M | 336.00M | 362.79M | 740.92M |
| Accounts Receivable | 455.83M | 439.66M | 308.45M | 234.21M | 231.07M | 90.97M |
| Other Receivables | 1.61M | |||||
| Receivables | 455.83M | 441.27M | 308.45M | 234.21M | 231.07M | 90.97M |
| Inventory | 137.13M | 176.47M | 141.86M | 127.60M | 100.12M | 53.91M |
| Prepaid Expenses | 108.26M | 64.64M | 38.95M | 48.61M | 45.02M | 40.48M |
| Total Current Assets | 933.02M | 825.21M | 1.09B | 746.42M | 739.01M | 926.29M |
| Property, Plant & Equipment | 84.27M | 82.14M | 75.03M | 74.94M | 75.57M | 8.79M |
| Goodwill | 581.73M | 580.36M | 416.82M | 416.82M | 409.05M | |
| Other Intangible Assets | 922.44M | 981.47M | 401.83M | 472.88M | 546.65M | |
| Long-Term Deferred Tax Assets | 3.85M | 4.39M | 44.43M | 155.43M | ||
| Other Long-Term Assets | 55.94M | 56.15M | 80.60M | 17.82M | 26.80M | 13.91M |
| Total Assets | 2.58B | 2.53B | 2.06B | 1.73B | 1.84B | 1.10B |
| Accounts Payable | 23.61M | 20.90M | 10.25M | 11.82M | 17.69M | 1.54M |
| Accrued Expenses | 111.86M | 144.92M | 128.85M | 100.68M | 97.66M | 22.16M |
| Current Portion of Long-Term Debt | 208.97M | 13.33M | 89.42M | |||
| Current Portion of Leases | 11.28M | 2.10M | 2.28M | |||
| Current Unearned Revenue | 1.75M | |||||
| Total Current Liabilities | 344.44M | 177.09M | 139.10M | 112.49M | 130.79M | 117.15M |
| Long-Term Debt | 1.94B | 2.14B | 1.51B | 1.50B | 1.49B | 787.25M |
| Long-Term Leases | 31.88M | 23.29M | 32.20M | 32.69M | 544.00K | |
| Long-Term Unearned Revenue | 2.53M | |||||
| Long-Term Deferred Tax Liabilities | 49.06M | 42.92M | ||||
| Other Long-Term Liabilities | 70.80M | 90.57M | 54.76M | 5.52M | 15.47M | |
| Total Liabilities | 2.43B | 2.48B | 1.70B | 1.65B | 1.67B | 907.48M |
| Common Stock | 114.00K | 118.00K | 123.00K | 127.00K | 135.00K | 138.00K |
| Additional Paid-In Capital | 12.00M | 2.41M | 27.37M | 256.35M | ||
| Retained Earnings | 151.26M | 54.79M | 359.87M | 90.55M | 143.22M | -58.91M |
| Comprehensive Income & Other | -7.83M | -18.09M | 3.83M | -9.28M | -922.00K | -620.00K |
| Shareholders' Equity | 143.54M | 48.81M | 363.82M | 83.81M | 169.80M | 196.95M |
| Total Liabilities & Equity | 2.58B | 2.53B | 2.06B | 1.73B | 1.84B | 1.10B |
| Total Debt | 2.18B | 2.18B | 1.51B | 1.53B | 1.54B | 879.49M |
| Net Cash (Debt) | -1.95B | -2.03B | -909.72M | -1.20B | -1.18B | -138.57M |
| Net Cash Per Share | -15.93 | -16.42 | -7.03 | -8.91 | -8.38 | -0.94 |
| Filing Date Shares Outstanding | 113.50M | 118.02M | 123.15M | 126.82M | 135.37M | 137.70M |
| Total Common Shares Outstanding | 114.04M | 117.78M | 123.14M | 126.77M | 135.15M | 137.50M |
| Working Capital | 588.59M | 648.12M | 946.24M | 633.93M | 608.22M | 809.14M |
| Book Value Per Share | 1.26 | 0.41 | 2.95 | 0.66 | 1.26 | 1.43 |
| Tangible Book Value | -1.36B | -1.51B | -454.83M | -805.89M | -785.90M | 196.95M |
| Tangible Book Value Per Share | -11.93 | -12.85 | -3.69 | -6.36 | -5.81 | 1.43 |
| Machinery | 73.62M | 68.20M | 57.53M | 50.78M | 43.13M | 18.26M |
| Leasehold Improvements | 7.52M | 7.52M | 7.01M | 6.99M | 6.73M | 1.63M |
| Order Backlog | 289.50M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 413.60M | 316.89M | 444.09M | 281.59M | 202.13M | 402.71M |
| Depreciation & Amortization | 114.80M | 88.05M | 81.31M | 84.86M | 49.64M | 3.00M |
| Other Amortization | 8.31M | 7.51M | 7.35M | 7.30M | 7.84M | 3.64M |
| Loss (Gain) From Sale of Assets | 2.70M | 2.62M | 1.53M | 611.00K | 129.00K | |
| Asset Writedown & Restructuring Costs | 333.59M | 333.59M | ||||
| Loss (Gain) From Sale of Investments | -1.25M | -3.47M | -10.93M | -6.32M | 2.83M | 2.26M |
| Stock-Based Compensation | 63.07M | 51.56M | 43.38M | 36.62M | 24.40M | 20.82M |
| Other Operating Activities | 21.27M | 7.06M | 1.60M | 22.58M | 39.09M | -136.72M |
| Change in Accounts Receivable | -137.56M | -128.06M | -74.25M | -3.34M | -83.94M | 6.75M |
| Change in Inventory | 63.39M | 2.55M | -67.38M | -26.88M | -17.48M | 7.37M |
| Change in Accounts Payable | -21.15M | 6.21M | 46.99M | -12.55M | 24.54M | 1.17M |
| Change in Other Net Operating Assets | -42.15M | -32.96M | 5.36M | 4.10M | -9.06M | -11.55M |
| Operating Cash Flow | 818.60M | 651.56M | 479.06M | 388.57M | 240.11M | 299.44M |
| Capital Expenditures | -12.37M | -6.97M | -10.70M | -15.29M | -4.81M | -1.46M |
| Sale of Property, Plant & Equipment | 26.01M | |||||
| Cash Acquisitions | -725.25M | -725.97M | -999.12M | |||
| Sale (Purchase) of Intangibles | -287.77M | -287.77M | ||||
| Investment in Securities | 419.68M | 474.89M | -252.03M | -81.61M | 490.92M | -404.83M |
| Investing Cash Flow | -605.72M | -545.81M | -262.72M | -96.91M | -487.00M | -406.29M |
| Short-Term Debt Issued | 370.00M | |||||
| Long-Term Debt Issued | 1.47B | 702.00M | 784.88M | |||
| Total Debt Issued | 1.47B | 1.47B | 1.07B | 784.88M | ||
| Short-Term Debt Repaid | -370.00M | |||||
| Long-Term Debt Repaid | -845.43M | -13.48M | -77.45M | -369.06M | ||
| Total Debt Repaid | -845.43M | -845.43M | -13.48M | -447.45M | -369.06M | |
| Net Debt Issued (Repaid) | 624.57M | 624.57M | -13.48M | 624.55M | 415.81M | |
| Issuance of Common Stock | 25.49M | 21.83M | 31.14M | 7.88M | 14.05M | 12.54M |
| Repurchase of Common Stock | -371.61M | -342.37M | -250.00M | -402.38M | -200.00M | -350.06M |
| Other Financing Activities | -389.20M | -389.20M | -76.22M | -424.00K | ||
| Financing Cash Flow | -110.75M | -85.17M | -218.86M | -407.99M | 362.37M | 77.86M |
| Net Cash Flow | 102.12M | 20.57M | -2.52M | -116.33M | 115.48M | -28.98M |
| Free Cash Flow | 806.22M | 644.59M | 468.37M | 373.28M | 235.30M | 297.98M |
| Free Cash Flow Margin | 48.46% | 46.15% | 46.13% | 45.01% | 35.64% | 67.22% |
| Free Cash Flow Per Share | 6.60 | 5.20 | 3.62 | 2.78 | 1.67 | 2.03 |
| Levered Free Cash Flow | 337.31M | 184.83M | 402.48M | 275.68M | 146.42M | 197.82M |
| Unlevered Free Cash Flow | 341.69M | 188.65M | 406.44M | 280.10M | 149.17M | 198.88M |
| Cash Interest Paid | 11.43M | 11.43M | 10.56M | 11.41M | 6.11M | 3.30M |
| Cash Income Tax Paid | 134.64M | 134.64M | 80.62M | 31.76M | 16.22M | -375.00K |
| Change in Working Capital | -137.47M | -152.26M | -89.28M | -38.67M | -85.95M | 3.74M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.64B | 7.91B | 6.08B | 4.88B | 7.69B | 5.66B |
| Enterprise Value | 16.58B | 8.75B | 6.95B | 5.93B | 8.94B | 5.72B |
| Last Close Price | 128.95 | 67.30 | 47.81 | 36.96 | 56.90 | 40.21 |
| PE Ratio | 38.13 | 24.98 | 13.70 | 17.34 | 38.06 | 14.05 |
| Forward PE | 13.03 | 8.85 | 10.38 | 9.77 | 21.92 | 17.89 |
| PS Ratio | 8.80 | 5.67 | 5.99 | 5.89 | 11.65 | 12.76 |
| PB Ratio | 102.45 | 162.13 | 16.72 | 58.26 | 45.31 | 28.73 |
| P/TBV Ratio | 28.73 | |||||
| P/FCF Ratio | 18.15 | 12.28 | 12.99 | 13.08 | 32.70 | 18.99 |
| P/OCF Ratio | 17.88 | 12.15 | 12.70 | 12.56 | 32.04 | 18.90 |
| PEG Ratio | 0.55 | 0.55 | 0.90 | 0.91 | 0.46 | |
| EV/Sales Ratio | 9.97 | 6.27 | 6.85 | 7.15 | 13.54 | 12.91 |
| EV/EBITDA Ratio | 15.78 | 9.75 | 11.09 | 14.22 | 26.60 | 20.63 |
| EV/EBIT Ratio | 17.56 | 10.72 | 12.61 | 17.56 | 30.89 | 20.74 |
| EV/FCF Ratio | 20.57 | 13.58 | 14.84 | 15.88 | 37.99 | 19.20 |
| Debt / Equity Ratio | 15.18 | 44.60 | 4.14 | 18.27 | 9.07 | 4.47 |
| Debt / EBITDA Ratio | 2.05 | 2.40 | 2.38 | 3.59 | 4.54 | 3.15 |
| Debt / FCF Ratio | 2.70 | 3.38 | 3.21 | 4.10 | 6.55 | 2.95 |
| Net Debt / Equity Ratio | 13.57 | 41.68 | 2.50 | 14.26 | 6.94 | 0.70 |
| Net Debt / EBITDA Ratio | 1.85 | 2.27 | 1.45 | 2.87 | 3.50 | 0.50 |
| Net Debt / FCF Ratio | 2.42 | 3.16 | 1.94 | 3.20 | 5.01 | 0.47 |
| Asset Turnover | 0.72 | 0.61 | 0.54 | 0.46 | 0.45 | 0.53 |
| Inventory Turnover | 2.48 | 1.95 | 1.77 | 2.36 | 2.67 | 2.04 |
| Quick Ratio | 1.99 | 3.30 | 6.50 | 5.07 | 4.54 | 7.10 |
| Current Ratio | 2.71 | 4.66 | 7.80 | 6.63 | 5.65 | 7.91 |
| Return on Equity (ROE) | 173.67% | 153.59% | 198.42% | 222.07% | 110.23% | 231.44% |
| Return on Assets (ROA) | 25.49% | 22.24% | 18.16% | 11.80% | 12.28% | 20.47% |
| Return on Invested Capital (ROIC) | 32.12% | 33.01% | 34.44% | 20.77% | 27.92% | 105.98% |
| Return on Capital Employed (ROCE) | 42.30% | 34.80% | 28.70% | 20.80% | 16.90% | 27.90% |
| Earnings Yield | 2.62% | 4.00% | 7.30% | 5.77% | 2.63% | 7.12% |
| FCF Yield | 5.51% | 8.14% | 7.70% | 7.65% | 3.06% | 5.27% |
| Buyback Yield / Dilution | 4.21% | 4.26% | 3.56% | 4.56% | 4.21% | -3.77% |